This will be replaced by the player.

Perrigo Company plc (PRGO) Soars on Takeover Approach from Mylan NV (MYL)

April 8th, 2015

prgo

Shares of Perrigo Company plc (NYSE:PRGO) touched a new 52-week high of $215.73 during Wednesday’s trading session, following the announcement that Mylan N.V. (Nasdaq:MYL) has made a proposal to acquire the company in a cash-and-stock transaction that would create a diversified, global pharmaceutical leader with an unmatched commercial and operating platform and a unique, one-of-a-kind profile.

The combination of these highly complementary businesses would produce a company with critical mass in specialty brands, generics, over-the-counter (OTC) and nutritional products; a powerful commercial platform with reach across all customer channels; an exceptional high-quality operating platform; and opportunities to generate enhanced growth and deliver significant immediate and long-term value and benefits for shareholders and the other stakeholders of both companies.

Under the terms of the non-binding proposal, which was recently delivered to PRGO‘s Chairman, PRGO shareholders would receive $205 in a combination of cash and MYL stock for each PRGO share.

The price of MYL stock also reached a new one-year high of $70.21 per share in intraday trading on Wednesday.

Perrigo Company plc (NYSE:PRGO),  a top five global over-the-counter (OTC) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices.

Mylan N.V. (Nasdaq:MYL) is a global pharmaceutical company committed to setting new standards in healthcare.

*

Read Full Disclaimer at www.drstockpick.com/disclaimer

 
Share/Bookmark
 

(Read Full Disclaimer at http://drstockpick.com/disclaimer

 
 

Crown Equity Holdings (CRWE) Operational Update; BIND Therapeutics (BIND) and Pfizer (PFE) Accurins Deal Timeline Extended

April 5th, 2015

http://drstockpick.com/wp-content/uploads/crwe_logo5.jpg Crown Equity Holdings Inc. (CRWE)

The company is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites.

CRWE Network‘s business model is based on selling advertising to businesses targeting both locally and nationally

The CRWE Network has reached the 1487th community website in the U.S. and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.

http://drstockpick.com/wp-content/uploads/crwejan16.jpg

http://drstockpick.com/wp-content/uploads/crwe_network_business_direc.jpg The CRWE-PR Business Directory portal ( www.BusinessDirectory.crwe-pr.com ) is the company’s business directory service that is available to all United States and Canada business in the public and private sector. It allows business owners and executives the ability to claim their business listings and provide more detailed information for their potential customers who visit the CRWE Network everyday.

http://drstockpick.com/wp-content/uploads/finance_crwe_pr.jpg The CRWE-PR Finance website ( www.finance.crwe-pr.com ) allows Crown Equity Holdings the instant distribution of breaking business and financial news to the entire CRWE Network

http://drstockpick.com/wp-content/uploads/press.jpg The company’s CRWE Press Release ( www.crwepressrelease.com ) offers increased visibility with cost effective solutions through the distribution of information to the entire CRWE Network for both public and private companies.

http://drstockpick.com/wp-content/uploads/crwerealestate.jpg Crown Equity Holdings’ CRWE Real Estate ( www.CRWERealEstate.com ) is expected to be integrated in all the CRWE Network. It will allow people to submit their listings for exposure to visitors searching for homes.

http://drstockpick.com/wp-content/uploads/crwetube.jpg Online video is gaining strength as a source for content marketing. Strategic plans are being developed for the company’s division CRWE Tube ( www.crwetube.com ), expected to be integrated in all the CRWE Network

http://drstockpick.com/wp-content/uploads/crwe_medical_marijuana.jpg The Medical Marijuana CRWE-PR website ( www.medicalmarijuana.crwe-pr.com ) is a news and information database of medical marijuana doctors, dispensaries, deliveries and lawyers across the nation.

http://drstockpick.com/wp-content/uploads/ib2b.jpgCRWE‘s subsidiary EQCO2, Inc. (CLNO) is in the process of changing its name for iB2B Global and its direction of operations to that of a business to business (B2B) international e-commerce company with an online and mobile optimized platform to facilitate e-commerce between manufacturers and buyers.

CRWE‘s iB2B Global ( www.iB2BGlobal.com ) was created to bring business communities from similar and different continents together online, enabling a cost effective access point for bulk products to be bought, sold and shipped in a timely manner.

avot CRWE has signed a Letter of Intent (LOI) to acquire 95% stake in American Video Teleconferencing Corp. (AVOT), which has two (2) sub-company operations known as, Roxzu and AVOTube.

http://drstockpick.com/wp-content/uploads/roxzu.jpg Roxzu ( www.roxzu.com ) in development stage, is an on-line e-commerce coupon distribution channel and marketplace for merchants to create brand awareness for their business. The geo-location based mobile marketing application Roxzu is expected to be integrated in all the CRWE Network.

http://drstockpick.com/wp-content/uploads/avotube.jpg AVOTube ( www.avotube.com ) is a video-sharing hosting service that allows user to upload videos to share for exposure, branding, marketing and advertising.

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

http://drstockpick.com/wp-content/uploads/bind.jpg  BIND Therapeutics, Inc. (BIND)

The price of BIND stock surged in extended-hours trading Thursday after the company announced an extension of the terms of its global collaboration with pharmaceutical giant Pfizer Inc. (PFE) to create Accurins that optimize the therapeutic potential of two molecularly targeted oncology drugs in Pfizer’s pipeline.

The timeline for Pfizer to exercise its option to acquire the exclusive license for the first program continues to be September 2015. BIND and Pfizer agreed to an extension of the timeline for the second program through March 2016.

Both companies mutually agreed to extend the research terms for the second of the two selected compounds in order to ensure it is fully evaluated and well-positioned to enter IND-enabling studies

BIND received an upfront payment of $4.0 million in 2013, a $1.0 million preclinical development milestone in December 2014, and has the potential to receive payments up to $88.5 million upon the achievement of additional specified development and regulatory events. BIND may also receive additional payments up to $110 million for specified commercial events as well as royalties in the low single to high single digit percentages on potential future sales of each Accurin commercialized, if any.

BIND‘s Accurins are polymeric nanoparticles that incorporate a therapeutic payload and are designed to have prolonged circulation within the bloodstream, enable targeting of the diseased tissue or cells, and provide for the controlled and timely release of the therapeutic payload

Shares of BIND surged $0.13 (or +2.41%) to $5.52 in the last trading session

http://drstockpick.com/wp-content/uploads/bindch2.png

BIND is a clinical-stage nanomedicine platform company developing a pipeline of Accurins, its novel targeted therapeutics designed to increase the concentration and duration of therapeutic payloads at disease sites while reducing exposure to healthy tissue. BIND has demonstrated in preclinical studies that Accurins can improve tumor growth suppression, achieve higher concentrations of the payload in tumors compared to the payload administered in conventional form, and have pharmacokinetics and tolerability differentiated from their therapeutic payloads.

More about BIND Therapeutics, Inc. (BIND) at www.bindtherapeutics.com

**

Disclaimer: DrStockPick.com is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at www.DrStockPick.com/disclaimer

 
Share/Bookmark
 

(Read Full Disclaimer at http://drstockpick.com/disclaimer

 
 

Altera (ALTR) Soars on Potential Merger with Intel (INTC)

March 27th, 2015

altr

Shares of Altera Corp. (Nasdaq:ALTR) touched a new 52-week high of $45.00 during Friday’s trading session, following media reports indicating that tech giant Intel Corporation (Nasdaq:INTC) is in talks to acquire the company

ALTR recently reported fourth quarter 2014 sales of $479.9 million and net income of $111.1 million, $0.36 per diluted share for the period

Altera Corp. (Nasdaq:ALTR) is at the forefront of technology innovation, providing customers programmable solutions for leading-edge electronic systems that are shaping our modern world.

*

Read Full Disclaimer at www.drstockpick.com/disclaimer

 
Share/Bookmark
 

(Read Full Disclaimer at http://drstockpick.com/disclaimer

 
 

XO Group (XOXO) Rating Boosted, Bridge Capital Holdings (BBNK) Soars on Merger Deal with Western Alliance Bancorporation (WAL)

March 10th, 2015

Shares of XO Group Inc. (NYSE:XOXO) surged on Tuesday, after the company delivered strong performance on its quarterly financial results with revenue and profit numbers above analysts’ expectations.

For the fourth quarter 2014, XOXO posted revenue of $37.1 million, a 13.7% increase year over year, and non-GAAP earnings per share of $0.06 compared to $0.02 in the same quarter the prior year, exceeding the Capital IQ Consensus Estimate of ($0.03) loss per share on revenue of $34.34 million for the period

Brokerage firm Stifel has upgraded the company’s stock from Hold to Buy with a price target of $20.00 per share

XO Group Inc. (NYSE:XOXO), a consumer Internet and media company, provides multiplatform media services to the wedding, nesting, and first-time pregnancy markets in the United States.

*

Bridge Capital Holdings (Nasdaq:BBNK) and Western Alliance Bancorporation (NYSE:WAL) reported that they have signed a definitive agreement pursuant to which WAL will acquire BBNK for approximately $425 million

Immediately following the completion of the acquisition, BBNK’s principal operating subsidiary, Bridge Bank, will merge with and into Western Alliance Bank, a wholly owned subsidiary of WAL

The Agreement provides that each shareholder of BBNK will receive 0.8145 of a share of WAL and $2.39 in cash for each share of BBNK common stock owned.

The transaction, expected to be completed in the fourth quarter of 2015, has been approved by the board of directors of each company and is subject to customary closing conditions

BBNK stock touched a new 52-week high during intraday trading on Tuesday

Bridge Capital Holdings (Nasdaq:BBNK) is the holding company for Bridge Bank, National Association (N.A.)

Western Alliance Bancorporation (NYSE:WAL) is a leading bank holding company providing comprehensive business banking and related financial services through its wholly owned banking subsidiary, Western Alliance Bank.

*

Read Full Disclaimer at www.drstockpick.com/disclaimer

 
Share/Bookmark
 

(Read Full Disclaimer at http://drstockpick.com/disclaimer

 
 

RTI International Metals (RTI) Skyrockets on Acquisition Deal with Alcoa (AA)

March 9th, 2015

aa

Shares of RTI International Metals, Inc. (NYSE:RTI) skyrocketed on Monday’s trading session, following the announcement that Alcoa Inc. (NYSE:AA) has signed a definitive agreement to acquire all outstanding shares of RTI in a stock-for-stock transaction

Under the terms of the agreement, RTI shareholders will receive 2.8315 AA shares for each RTI share

The acquisition will offer Alcoa financial benefits with realized net synergies of about $100 million in 2019, primarily driven by procurement and productivity improvements, leveraging Alcoa’s global shared services and driving profitable growth.

Alcoa expects RTI to contribute $1.2 billion in revenues in 2019, up from $794 million generated in 2014, with 65% of revenues supported by contracts over the next five years. RTI is expected to reach profitability of 25% EBITDA margin in 2019, up from 14.5% in 2014.

RTI stock touched a new 52-week high during intraday trading.

Alcoa Inc. (NYSE:AA) is a global leader in lightweight metals technology, engineering and manufacturing

RTI International Metals, Inc. (NYSE:RTI) is a leading vertically integrated global supplier of advanced titanium and specialty metal products and services to commercial aerospace, defense, energy, medical device and other customers across the entire supply chain.

*

Read Full Disclaimer at www.drstockpick.com/disclaimer

 
Share/Bookmark
 

(Read Full Disclaimer at http://drstockpick.com/disclaimer

 
 

Latest News